Insider buying last 90 days
No open-market insider purchases were filed for MCK in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MCK insider filing, plotted on the chart in Gekko.Open MCK in Gekko
NYSE: MCK
McKesson (MCK) Stock Analysis & Forecast
Nov 4 close
$1,069.44+69.82 (+7.0%)
Gekko Brief
AI summaryNov 4 closeMcKesson beat second-quarter estimates and raised full-year guidance, reporting adjusted EPS of $11.68 on revenue of $111.0 billion, with shares reaching an all-time high of $1,030.50 before dipping 0.8% on the day. The prior quarter had already topped expectations with revenue up 8% to $105 billion and adjusted EPS of $9.93, a 20% increase, with three of four segments posting double-digit operating profit growth. Coverage also noted an officer's proposed sale of 600 shares valued at $630,000, tied to restricted stock vesting.
MCK closes at $1069.44, up 7% on the day and above both its 50-day average of $930.78 and 200-day average of $865.42, with one-month and six-month returns of 16% and 43.8%. The GekkoIndex sits at 42, placing the stock in the Distribution zone, down 11.6 over the past five days. Price trades 1.7% above Gekko Fair Value of $1051.61.
No confirmed earnings date is on the calendar following the last report on 5 August 2026, which beat estimates by $9.93 versus $9.44 and produced a 4.9% reaction, part of a stretch of 8 beats in 8 quarters with an average absolute move of 5.9%. Over the last 90 days, Congress recorded 2 buys and 0 sells, with one billionaire holder and one trailblazer holder noted. Analyst coverage from 15 firms shows 12 buy and 3 hold ratings, with a consensus target of $1026.07, implying -4.1% versus current price. Seasonally, the next 20 trading days have averaged a 1.8% return over 5 years, rising in 2 of those years.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
McKesson price vs fair value
Close $1,069.44200-day averageGekko Fair Value $1,051.61
McKesson quick facts
- Market cap
- $124.6B
- P/E ratio
- 26.8
- Forward P/E
- 22.2
- EPS, TTM
- $37.31
- Revenue, TTM
- $411.0B
- Profit margin
- 1.1%
- Dividend yield
- 0.33%
- Beta
- 0.28
- Volume
- 1.17M avg 699,372
- 1-year return
- +30.4%
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±4.7%
- 50-day average
- $930.78
- 200-day average
- $865.42
- Next earnings
- —
- Shares outstanding
- 116.6M
McKesson swing-trade checklist
McKesson scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $1069.44 is above the 50-day ($930.78) and 200-day ($865.42) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexheadwind
42, Distribution
Reading 42 is in the Distribution zone.
See the GekkoIndex - Fair valuemixed
1.7% above
Price is within 5% of Gekko Fair Value (1.7% above).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: Congress 2 buys / 0 sales.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
See earnings - Seasonalitymixed
+1.8% on average
From this point in the calendar, the next 20 trading days averaged +1.8% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
McKesson stock chart and price history
McKesson closed at $1,069.44 on Nov 4, 2026, +30.4% over the past year, inside a 52-week range of $723.68 to $1,073.95.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +16.0%
- 3 months
- +22.7%
- 6 months
- +43.8%
- 1 year
- +30.4%
The full MCK chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MCK in Gekko
Follow McKesson through every session
Put MCK on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MCK in GekkoFree for 7 days. No credit card required.
About McKesson
McKesson distributes pharmaceutical and other healthcare products, working with pharmacies, medical practices, and healthcare providers across the United States and abroad. It handles branded, generic, specialty, biosimilar, and over-the-counter medicines, and is also known for supporting oncology and specialty practices with management tools, technology, and clinical guidance.
The company runs through four segments. Its U.S. Pharmaceutical business supplies medicines and offers consulting, outsourcing, and software services to pharmacies. A separate international segment distributes products and provides support to wholesale, institutional, and retail customers in thirteen European countries and Canada. The Medical-Surgical Solutions unit supplies medical-surgical products and logistics support to healthcare providers, while the Prescription Technology Solutions segment works with biopharmaceutical and life sciences companies to help patients access and stay on medications, linking pharmacies, providers, payers, and drugmakers, and adding third-party logistics and wholesale distribution services.
McKesson traces its founding to 1833 and is headquartered in Irving, Texas. Its shares are listed on the NYSE under the ticker MCK.
- Listed
- NYSE
- Sector
- Distribution services
- Industry
- Medical distributors
- Website
- mckesson.com
McKesson GekkoIndex: the smart money zone
McKesson’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 42, in the Distribution zone, down 11.6 points over five sessions.
42Distribution
Down 11.6 points over five sessions, from the Neutral zone.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 23 | −0.2% | −0.6% | ||
| Accumulation | 157 | +0.5% | 0.0% | ||
| Neutral | 456 | +0.9% | +3.8% | ||
| Distribution (current zone) | 55 | −1.3% | −2.4% | ||
| Selling | 6 | Too few readings yet | |||
Average MCK share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
See every daily GekkoIndex reading plotted over the MCK price, zone by zone.Track MCK in Gekko
Is McKesson stock overvalued? Gekko Fair Value
McKesson trades 1.7% above Gekko Fair Value of $1,051.61, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what McKesson shares are worth, recalculated every trading day.
$1,051.61
Gekko Fair Value, Nov 4, 2026
1.7% above fair value · About fair value
At the end of Aug 2026 the price was 15.3% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open MCK in Gekko
McKesson insider and Congress trading
No open-market insider purchases were filed for McKesson, and members of Congress disclosed 2 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
2trades disclosed: 2 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Oct 9 traded Sep 4 |
| Ro Khanna House, CA, purchase | $1,001 - $15,000 | Sep 7 traded Aug 10 |
From congressional disclosures, which report amounts as ranges.
Buybacks
McKesson has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $2.53B
- As a share of market cap
- 2.03%
- Trailing four quarters
- $6.46B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold MCK.
1added0opened1trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
McKesson earnings: next date and track record
McKesson beat the EPS estimate in 8 of its last 8 reports, moving 5.9% on average across the report.
8 of 8reports beat the EPS estimate
±5.9%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 5, 2026 AI summary
- What they said
- McKesson reported Q1 FY27 revenues up 8% to $105 billion with adjusted EPS of $9.93, a 20% increase, both exceeding expectations. Three of four reporting segments delivered double-digit operating profit growth. The company serves 14,000+ providers across oncology/multispecialty platforms and is expanding AI capabilities and cell/gene therapy access through Inspira-Gene.
- Guidance
- McKesson raised full-year adjusted EPS guidance to $44.20-$45.00, up from prior range of $43.80-$44.60, reflecting confidence from strong Q1 performance and broad-based momentum across the enterprise.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $9.93 est $9.44 | $105.4B est $103.9B | +4.9% |
| May 7, 2026 | $11.69 est $11.57 | $96.30B est $101.3B | −1.0% |
| Feb 4, 2026 | $9.34 est $9.17 | $106.2B est $105.8B | +12.5% |
| Nov 5, 2025 | $9.86 est $9.03 | $103.2B est $104.1B | +2.0% |
| Aug 6, 2025 | $8.26 est $8.14 | $97.83B est $96.18B | −6.5% |
| May 8, 2025 | $10.12 est $9.83 | $90.82B est $94.30B | −4.0% |
| Feb 5, 2025 | $8.03 est $7.99 | $95.29B est $96.05B | −0.6% |
| Nov 6, 2024 | $7.07 est $6.87 | $93.65B est $89.33B | +15.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
McKesson stock forecast and analyst price targets
Analysts’ average 12-month price target for McKesson is $1,026.07, −4.1% from the last close, from 15 firms rating the stock in the last 90 days.
$1,026.07consensus 12-month target, −4.1% from the last close
Now $1,069.44Avg $1,026.07
Low $845High $1,200
Each firm’s latest rating in the last 90 days: 15 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 20 | Mizuho Securities | $1,020 | −4.6% |
| Oct 16 | UBS | $1,200 | +12.2% |
| Oct 7 | Leerink Partners | $1,070 | +0.1% |
| Oct 6 | Morgan Stanley | $977 | −8.6% |
| Oct 6 | Evercore ISI | $1,000 | −6.5% |
−2.4%average 20-day move after past Distribution readings
+1.8%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
McKesson seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, McKesson averaged +1.8% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.4% | 3 of 5 |
| Next 10 trading days | +2.6% | 3 of 5 |
| Next 15 trading days | +4.0% | 3 of 5 |
| Next 20 trading days | +1.8% | 2 of 5 |
| Next 30 trading days | +0.2% | 2 of 5 |
For scale, MCK’s typical 20-trading-day move in either direction is about 4.7%.
McKesson market cap and key statistics
McKesson’s market cap is $124.6B, with a P/E ratio of 26.8 and revenue of $411.0B over the last twelve months.
Valuation
- Market cap
- $124.6B
- P/E ratio
- 26.8
- Forward P/E
- 22.2
- EPS, TTM
- $37.31
- Gekko Fair Value
- $1,051.61
Trading
- Volume
- 1.17M
- Avg volume, 20 days
- 699,372
- 52-week high
- $1,073.95
- 52-week low
- $723.68
- Shares outstanding
- 116.6M
Financials
- Revenue, TTM
- $411.0B
- Profit margin
- 1.1%
- Return on equity
- 0%
- Quarterly earnings growth, YoY
- −17.6%
Risk and income
- Beta
- 0.28
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±4.7%
- Dividend yield
- 0.33%
McKesson stock news this week
Coverage of McKesson this week reads positive: 14 positive, 5 neutral and 0 negative headlines.
- Officer Francisco Fraga proposes selling 600 shares of McKesson (MCK).Stock Titan, Nov 4
- McKesson beats Q2 estimates, raises full-year guidanceInvesting.com, Nov 4
- Here's What Key Metrics Tell Us About McKesson (MCK) Q2 EarningsZacks Investment Research, Nov 4
- McKesson (MCK) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research, Nov 4
- Mckesson stock hits all-time high at 1030.5 USD By Investing.comInvesting.com South Africa, Nov 4
- Mckesson stock hits all-time high at 1030.5 USDInvesting.com, Nov 4
McKesson peers
McKesson’s 3 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| CORCencora | Distribution | 19.3% below |
| CAHCardinal Health | Neutral | 35.1% below |
| HSICHenry Schein | Neutral | 6.6% above |
A peer links to its own page where one exists.
McKesson stock FAQ
What is McKesson’s market cap?
McKesson’s market cap is $124.6B at the Nov 4, 2026 close of $1,069.44, with 116.6M shares outstanding. The shares trade on a P/E ratio of 26.8.
What is the McKesson stock forecast?
The consensus analyst 12-month price target for McKesson is $1,026.07, −4.1% from the last close. Of the 15 firms that rated the stock in the last 90 days, 12 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is McKesson stock overvalued or undervalued?
On Gekko’s estimate McKesson is about fair value: the Nov 4, 2026 close of $1,069.44 is 1.7% above Gekko Fair Value of $1,051.61. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is McKesson’s 52-week high and low?
McKesson’s 52-week high is $1,073.95 and its 52-week low is $723.68; it closed at $1,069.44 on Nov 4, 2026, +30.4% over the past year.
Is McKesson stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and smart money), 2 as mixed (fair value and seasonality) and 1 as a headwind (gekkoindex). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See McKesson the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.